Can Multiple Myeloma Be Cured? Experts Explain the New Definition of Cure
Can multiple myeloma actually be cured? For the first time, myeloma researchers and clinicians are formally discussing and defining what “cure” could mean for patients living with multiple myeloma. In this video, Dr. Joseph Mikhael and Beth Faiman from the International Myeloma Foundation explain: how cure differs from remission why MRD (minimal residual disease) testing matters what treatment-free remission could look like how imaging and bone marrow testing fit into the definition and how future clinical trials may be designed with curative intent This conversation reflects a major shift in the future of myeloma care and research, bringing new hope to newly diagnosed and relapsed myeloma patients alike. Topics Covered in this Video: 0:00 - Introduction 0:27 - Why are experts defining cure now? 0:54 - What does “cure” mean in multiple myeloma? 1:36 - How is cure different from remission? 2:30 - Could cure apply to relapsed myeloma too? 3:10 - Treatment-free remission explained 3:34 - Why MRD (minimal residual disease) testing matters 4:05 - Bone marrow and imaging requirements 4:21 - What curative intent means for future treatment 4:52 - How cure changes future clinical trials Don't miss this in-depth Q&A with Dr. Mikhael and Beth Faiman and be sure to submit your own questions using #AskTheIMF on Facebook, Instagram, or X. Learn more at myeloma.org. Like, Comment, and Subscribe for weekly updates on myeloma research, treatment, and patient support. Have a question that needs more personalized support? Call us! We’re here for you. The IMF’s InfoLine is available to answer your myeloma-related questions and concerns. Call us at 1-818-487-7455, email us at [email protected], or schedule your call at a time that works best for you at www.myeloma.org/infoline. _______________ Founded in 1990, the International Myeloma Foundation (IMF) is the world’s leading organization dedicated to multiple myeloma. The IMF is steadfast in its mission: improving the quality of life of myeloma patients while working toward prevention and a cure. The IMF serves people impacted by myeloma at every stage of the disease by combining world-class research, trusted education, global advocacy, and direct support. A cornerstone of this work is the International Myeloma Working Group® (IMWG)—a network of more than 300 internationally renowned researchers and clinicians who establish the guidelines that shape how myeloma is diagnosed, treated, and managed across the globe. Through its global network of support groups, educational programs, its 24/7 generative-AI myeloma assistant Myelo®, its InfoLine staff, and its advocacy for greater healthcare access, the IMF helps people living with myeloma and their care partners navigate diagnosis, treatment, and survivorship. At the same time, the IMF ensures scientific advances translate into better care and outcomes. The IMF is driven by its vision: A world where every myeloma patient can live life to the fullest, unburdened by the disease. Learn more at www.myeloma.org or contact the IMF InfoLine at (800) 452-CURE (2873) (U.S. & Canada), +1 (818) 487-7455 (worldwide), or [email protected]. Subscribe to our channel: / imfmyeloma Find us online: Facebook: @myeloma | / myeloma X/Twitter: @IMFMyeloma | / imfmyeloma Instagram: @imfmyeloma | / imfmyeloma LinkedIn: / international-myeloma-foundation Support the IMF | Donate Now! https://fundraise.myeloma.org/give/52... Category Nonprofits & Activism License Standard YouTube License The International Myeloma Foundation is committed to accessibility for all. That’s why all English-language videos uploaded to our YouTube channel feature human-transcribed closed captioning. This ensures more accurate captions for viewers who are Deaf or hard of hearing and improves the quality of automatic translations into other languages for our global audience.

What Happens After CAR T-Cell Therapy? Myeloma Experts Answer Common Questions

Top 10 Multiple Myeloma Breakthroughs from ASH 2025 | CAR-T & Bispecific Antibodies Explained

Ask the Expert: Relapsed/Refractory Multiple #Myeloma | Abhishek Pandey, MD

Myeloma 101: Understanding Multiple Myeloma, Risk Factors, Diagnosis & Treatments Explained

IMS 2025 Highlight: Myeloma Treatment Is Changing Fast | Mohamad Mohty, MD, PhD | #IMS2025

Beam Radiation Vs. Brachytherapy for #ProstateCancer | #MarkScholzMD #AlexScholz #PCRI

What Is Multiple Myeloma? A Simple Guide for Newly Diagnosed

What CLL Patients Should Know in 2025 with Alvaro Alencar, MD | HealthTree Webinar Series

13 Critically Important Symptoms of Multiple Myeloma (A Cancer that Occurs In the Bones)

Erin's Multiple Myeloma Story: From Back Pain to a Stage 3 Diagnosis | The Patient Story

Relapsed Multiple Myeloma: What Every Patient Needs to Know

Why Myeloma Treatments Stop Working, What Remission Really Means & More | Myeloma Questions Answered

A 17-year Fight Against Multiple Myeloma

2026 Updates in Multiple Myeloma Treatments | Dr. Sita Bhella

Ivermectin to Treat Cancer? Get the FACTS

THIS Is #1 FASTEST Way To BURN Fat Around Your Organs

Does Myeloma Come Back More Aggressively? MGUS, High-Risk & Dex Questions Answered

Multiple Myeloma 101 for 2025: Diagnosis, Prognosis, and Risk

Repurposed drugs for cancers

